Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024144442> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2024144442 endingPage "75" @default.
- W2024144442 startingPage "72" @default.
- W2024144442 abstract "Because ductal carcinoma in situ (DCIS) avidly expresses Her2/neu, the target of the monoclonal antibody trastuzumab, and because trastuzumab has been shown to be effective against invasive breast cancer, trastuzumab may be effective for reducing the tumor burden and abrogating or reversing the hypothesized transition from in situ to invasive disease in patients with DCIS. To test this hypothesis, a trial of neoadjuvant trastuzumab for DCIS has been opened at our institution. Because trastuzumab has been shown to act as a radiosensitizing agent for Her2/neu-overexpressing cancer and because there are currently no systemic treatments for estrogen-receptor-negative DCIS, it makes sense to investigate whether use of trastuzumab concurrently with postoperative radiation therapy improves local control of DCIS. The National Surgical Adjuvant Breast and Bowel Project (NSABP) is planning a trial to test this hypothesis. The risk of cardiac toxicity associated with the doses of trastuzumab planned for these trials (cumulative doses of 8 mg/kg for our trial and 14 mg/kg in the NSABP trial) is believed to be minimal, but the safety profile of these approaches will need to be closely monitored." @default.
- W2024144442 created "2016-06-24" @default.
- W2024144442 creator A5001315712 @default.
- W2024144442 creator A5042475462 @default.
- W2024144442 creator A5047511061 @default.
- W2024144442 creator A5058220968 @default.
- W2024144442 creator A5068491553 @default.
- W2024144442 creator A5071158497 @default.
- W2024144442 creator A5080151722 @default.
- W2024144442 creator A5084086867 @default.
- W2024144442 creator A5087724207 @default.
- W2024144442 date "2007-01-01" @default.
- W2024144442 modified "2023-10-15" @default.
- W2024144442 title "Novel Clinical Trial Designs for Treatment of Ductal Carcinoma In Situ of the Breast with Trastuzumab (Herceptin)" @default.
- W2024144442 cites W1867197625 @default.
- W2024144442 cites W1985385254 @default.
- W2024144442 cites W1990209394 @default.
- W2024144442 cites W1990582579 @default.
- W2024144442 cites W2018431511 @default.
- W2024144442 cites W2029538632 @default.
- W2024144442 cites W2030977182 @default.
- W2024144442 cites W2062713892 @default.
- W2024144442 cites W2082117763 @default.
- W2024144442 cites W2107426197 @default.
- W2024144442 cites W2132144488 @default.
- W2024144442 cites W2146821731 @default.
- W2024144442 cites W2318605753 @default.
- W2024144442 cites W2331142721 @default.
- W2024144442 cites W4375905852 @default.
- W2024144442 doi "https://doi.org/10.1111/j.1524-4741.2006.00366.x" @default.
- W2024144442 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17214797" @default.
- W2024144442 hasPublicationYear "2007" @default.
- W2024144442 type Work @default.
- W2024144442 sameAs 2024144442 @default.
- W2024144442 citedByCount "22" @default.
- W2024144442 countsByYear W20241444422012 @default.
- W2024144442 countsByYear W20241444422013 @default.
- W2024144442 countsByYear W20241444422014 @default.
- W2024144442 countsByYear W20241444422015 @default.
- W2024144442 countsByYear W20241444422016 @default.
- W2024144442 crossrefType "journal-article" @default.
- W2024144442 hasAuthorship W2024144442A5001315712 @default.
- W2024144442 hasAuthorship W2024144442A5042475462 @default.
- W2024144442 hasAuthorship W2024144442A5047511061 @default.
- W2024144442 hasAuthorship W2024144442A5058220968 @default.
- W2024144442 hasAuthorship W2024144442A5068491553 @default.
- W2024144442 hasAuthorship W2024144442A5071158497 @default.
- W2024144442 hasAuthorship W2024144442A5080151722 @default.
- W2024144442 hasAuthorship W2024144442A5084086867 @default.
- W2024144442 hasAuthorship W2024144442A5087724207 @default.
- W2024144442 hasBestOaLocation W20241444421 @default.
- W2024144442 hasConcept C121608353 @default.
- W2024144442 hasConcept C126322002 @default.
- W2024144442 hasConcept C143998085 @default.
- W2024144442 hasConcept C2777176818 @default.
- W2024144442 hasConcept C2777863537 @default.
- W2024144442 hasConcept C2779786085 @default.
- W2024144442 hasConcept C2780862961 @default.
- W2024144442 hasConcept C530470458 @default.
- W2024144442 hasConcept C535046627 @default.
- W2024144442 hasConcept C71924100 @default.
- W2024144442 hasConceptScore W2024144442C121608353 @default.
- W2024144442 hasConceptScore W2024144442C126322002 @default.
- W2024144442 hasConceptScore W2024144442C143998085 @default.
- W2024144442 hasConceptScore W2024144442C2777176818 @default.
- W2024144442 hasConceptScore W2024144442C2777863537 @default.
- W2024144442 hasConceptScore W2024144442C2779786085 @default.
- W2024144442 hasConceptScore W2024144442C2780862961 @default.
- W2024144442 hasConceptScore W2024144442C530470458 @default.
- W2024144442 hasConceptScore W2024144442C535046627 @default.
- W2024144442 hasConceptScore W2024144442C71924100 @default.
- W2024144442 hasIssue "1" @default.
- W2024144442 hasLocation W20241444421 @default.
- W2024144442 hasLocation W20241444422 @default.
- W2024144442 hasOpenAccess W2024144442 @default.
- W2024144442 hasPrimaryLocation W20241444421 @default.
- W2024144442 hasRelatedWork W1586390383 @default.
- W2024144442 hasRelatedWork W1722328147 @default.
- W2024144442 hasRelatedWork W1771722205 @default.
- W2024144442 hasRelatedWork W2015092588 @default.
- W2024144442 hasRelatedWork W2066747782 @default.
- W2024144442 hasRelatedWork W2098775844 @default.
- W2024144442 hasRelatedWork W2172254302 @default.
- W2024144442 hasRelatedWork W2464051959 @default.
- W2024144442 hasRelatedWork W2934076975 @default.
- W2024144442 hasRelatedWork W2342209702 @default.
- W2024144442 hasVolume "13" @default.
- W2024144442 isParatext "false" @default.
- W2024144442 isRetracted "false" @default.
- W2024144442 magId "2024144442" @default.
- W2024144442 workType "article" @default.